ALX Oncology Holdings Inc.
ALXO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $87,132 | $640,088 | $458,685 | $866,220 |
| - Cash | $17,567 | $22,406 | $48,822 | $363,667 |
| + Debt | $16,978 | $17,197 | $10,430 | $742 |
| Enterprise Value | $86,543 | $634,879 | $420,293 | $503,295 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$132,249 | -$158,404 | -$122,838 | -$83,420 |
| % Margin | – | – | – | – |
| Net Income | -$134,850 | -$160,805 | -$123,482 | -$83,463 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.58 | -3.74 | -3.03 | -2.07 |
| % Growth | 31% | -23.4% | -46.4% | – |
| Operating Cash Flow | -$121,912 | -$130,364 | -$89,223 | -$68,101 |
| Capital Expenditures | -$447 | -$1,274 | -$1,427 | -$4,923 |
| Free Cash Flow | -$122,359 | -$131,638 | -$90,650 | -$73,024 |